Antiresorptive Agents and Anti-Angiogenesis Drugs in the Development of Osteonecrosis of the Jaw (original) (raw)
Osteonecrosis of the Jaw and Angiogenesis inhibitors: A Revival of a Rare but Serous Side Effect
vanni balestri
Current Medicinal Chemistry
View PDFchevron_right
Angiogenesis in the Development of Medication-Related Osteonecrosis of the Jaws: An Overview
Christian Walter
Dentistry Journal, 2016
View PDFchevron_right
Risk profile for antiangiogenic agent-related osteonecrosis of the jaws
Journal einstein (São Paulo)
einstein (São Paulo), 2019
View PDFchevron_right
Workshop of European task force on medication‐related osteonecrosis of the jaw—Current challenges
Ourania Nicolatou-galitis
Oral Diseases, 2019
View PDFchevron_right
Osteonecrosis of the Jaws in Patients Receiving Anti-Angiogenic Drugs and Chemotherapeutics: Literature Review and Case Reports
Evgeniy Aleksiev
Acta Medica Bulgarica, 2019
View PDFchevron_right
Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS
Athanasios Anastasilakis
The Journal of Clinical Endocrinology & Metabolism, 2021
View PDFchevron_right
Drug-induced osteonecrosis of the jaw: the state of the art
F. Bertoldo
Reumatismo, 2017
View PDFchevron_right
In Vitro Cytotoxicity of Antiresorptive and Antiangiogenic Compounds on Oral Tissues Contributing to MRONJ: Systematic Review
Henry Owuama
Biomolecules
View PDFchevron_right
Osteonecrosis of the jaw related to non-antiresorptive medications: a systematic review
Kivanc Bektas-kayhan
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2018
View PDFchevron_right
What is the effect of anti-resorptive drugs (ARDs) on the development of medication-related osteonecrosis of the jaw (MRONJ) in osteoporosis patients: A systematic review
Riham Fliefel
Journal of Cranio-Maxillofacial Surgery, 2017
View PDFchevron_right
Prevalence of Osteonecrosis of the Jaw Secondary to Antiresorptive Therapy in Patients Who have Undergone Dental Surgical Procedures: A Retrospective Study
International Journal of Dentistry and Oral Science (IJDOS)
View PDFchevron_right
18 Years of Medication-Related Osteonecrosis of the Jaw (MRONJ) Research: Where Are We Now?—An Umbrella Review
Alessandro Acocella
Applied Sciences
View PDFchevron_right
Antiresorptive drug-related osteonecrosis of the jaw
Colonya Calhoun
Dental clinics of North America, 2014
View PDFchevron_right
Response to Letter to the Editor from Taguchi: “(Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS”
Athanasios Anastasilakis
The Journal of Clinical Endocrinology and Metabolism, 2022
View PDFchevron_right
The Dental Management of Patients at Risk of Medication-Related Osteonecrosis of the Jaw: New Paradigm of Primary Prevention
Vera Panzarella
BioMed Research International, 2018
View PDFchevron_right
A Review On Medication-Related Osteonecrosis Of The Jaw: Definition and Best Practice For Prevention, Diagnosis, and Treatment
International Journal of Dentistry and Oral Science (IJDOS)
SciDoc Publishers, 2021
View PDFchevron_right
Medication-related osteonecrosis of the jaw: definition and best practice for prevention, diagnosis, and treatment
Ourania Nicolatou-galitis
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 2018
View PDFchevron_right
Radiographic Evaluation of Medication-Related Osteonecrosis of the Jaw (MRONJ) With Different Primary Cancers and Medication Therapies
Kavya Shankar Muttanahally
Cureus
View PDFchevron_right
Medication related osteonecrosis of the jaws associated with targeted therapy as monotherapy and in combination with antiresorptives. A report of 7 cases from the Copenhagen Cohort
Ilana Kaplan
Oral surgery, oral medicine, oral pathology and oral radiology, 2018
View PDFchevron_right
Case reports of medication-related osteonecrosis of the jaw (MRONJ) treated with uncultured stromal vascular fraction and L-PRF
J. Widelec
Journal of Stomatology, Oral and Maxillofacial Surgery, 2020
View PDFchevron_right
Denosumab and anti-angiogenetic drug-related osteonecrosis of the jaw: an uncommon but potentially severe disease
Franco Lumachi
Anticancer research, 2013
View PDFchevron_right
Medication-related osteonecrosis of the jaw. Introduction of a new modified experimental model
Mariza Matsumoto
Acta Cirurgica Brasileira, 2016
View PDFchevron_right
Clinical management of maxillary osteonecrosis associated with antiresorptive medication (MRONJ): Presentation of clinical cases
silvana picardo
Journal of Internal Medicine: Science & Art
View PDFchevron_right
Drug-induced osteonecrosis of the jaw
Alois Lang
2012
View PDFchevron_right
Medication-Related Osteonecrosis of the Jaw: A Critical Narrative Review
Javier Carballo
Journal of Clinical Medicine, 2021
View PDFchevron_right
A Comprehensive Review of Differences between Osteoradionecrosis and Medication-related Osteonecrosis of the Jaw
Efsun Somay
Journal of Cancer and Tumor International
View PDFchevron_right
Epidemiology, clinical manifestations, risk reduction and treatment strategies of jaw osteonecrosis in cancer patients exposed to antiresorptive agents
Giuseppe Pizzo
Future Oncology, 2014
View PDFchevron_right
Proceedings of the Closed Round Table and Italian Consensus on the Medication-Related Osteonecrosis of Jaws (MRONJ) at the Symposium of Italian Society of Oral Pathology and Medicine (SIPMO) Ancona, 20 October 2018 - Part III
Vera Panzarella
Frontiers in Physiology
View PDFchevron_right